Boston Scientific Corporation BSX recently presented data supporting the use of the FARAPULSE Pulsed Field Ablation (“PFA”) ...

US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients ...

In a heartwarming story from the streets of Mumbai, a 70-year-old watchman called Guptaji has captured the city's heart with his extraordinary dedication to his ...

The East Texas Mega Heart Health Fair will be held from 10 a.m. to 2 p.m. Feb. 21 at Lufkin’s Pitser Garrison Convention Center.

Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.

TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Boston Scientific (BSX) announced data supporting the use of the FARAPULSE Pulsed Field Ablation System* and the WATCHMAN ...

Independence Health System’s Westmoreland Hospital announced that its Heart Lung and Vascular Institute specialists ...

Washington Regional’s Walker Heart Institute now offers the Watchman FLX Pro Left Atrial Appendage Closure (LAAC) Device. The ...